1. Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene. (22nd March 2021) Authors: Huo, Shengqi; Shi, Wei; Ma, Haiyan; Yan, Dan; Luo, Pengcheng; Guo, Junyi; Li, Chenglong; Lin, Jiayuh; Zhang, Cuntai; Li, Sheng; Lv, Jiagao; Lin, Li Other Names: Zhou Hao Academic Editor. Journal: Oxidative medicine and cellular longevity Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. Issue 3 (16th February 2019) Authors: Ma, Haiyan; Yan, Dan; Wang, Yina; Shi, Wei; Liu, Tianshu; Zhao, Chongqiang; Huo, Shengqi; Duan, Jialin; Tao, Jingwen; Zhai, Maocai; Luo, Pengcheng; Guo, Junyi; Tian, Lei; Mageta, Lulu; Jou, David; Zhang, Cuntai; Li, Chenglong; Lin, Jiayuh; Lv, Jiagao; Li, Sheng Journal: Cancer science Issue: Volume 110:Issue 3(2019) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blocking the IL-6––STAT3 signaling pathway: potential liver cancer therapy. (February 2011) Authors: Liu, Yan; Lin, Jiayuh Journal: Future oncology Issue: Volume 7:Number 2(2011) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blocking the IL-6––STAT3 signaling pathway: potential liver cancer therapy. (February 2011) Authors: Liu, Yan; Lin, Jiayuh Journal: Future oncology Issue: Volume 7:Number 2(2011) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer. (28th April 2019) Authors: Fu, Shengling; Chen, Xiang; Lo, Hui-Wen; Lin, Jiayuh Journal: Cancer letters Issue: Volume 448(2019) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells. Issue 6 (3rd June 2019) Authors: Ma, Ling; Wei, Jia; Su, Gloria H.; Lin, Jiayuh Journal: Cancer biology & therapy Issue: Volume 20:Issue 6(2019) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors. Issue 6 (15th March 2015) Authors: Daka, Philias; Liu, Aiguo; Karunaratne, Chamini; Csatary, Erika; Williams, Cameron; Xiao, Hui; Lin, Jiayuh; Xu, Zhenghu; Page, Richard C.; Wang, Hong Journal: Bioorganic & medicinal chemistry Issue: Volume 23:Issue 6(2015) Page Start: 1348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism. (January 2016) Authors: Zhao, Chengguang; Li, Huameng; Lin, Huey-Jen; Yang, Shulin; Lin, Jiayuh; Liang, Guang Journal: Trends in pharmacological sciences Issue: Volume 37:Number 1(2016) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inhibition of Interleukin‐6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice. Issue 8 (12th March 2020) Authors: Shi, Wei; Ma, Haiyan; Liu, Tianshu; Yan, Dan; Luo, Pengcheng; Zhai, Maocai; Tao, Jingwen; Huo, Shengqi; Guo, Junyi; Li, Chenglong; Lin, Jiayuh; Zhang, Cuntai; Li, Sheng; Lv, Jiagao; Lin, Li Journal: Journal of cellular and molecular medicine Issue: Volume 24:Issue 8(2020) Page Start: 4748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel activators and small-molecule inhibitors of STAT3 in cancer. (October 2019) Authors: Yang, Lehe; Lin, Shichong; Xu, Lingyuan; Lin, Jiayuh; Zhao, Chengguang; Huang, Xiaoying Journal: Cytokine & growth factor reviews Issue: Volume 49(2019) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗